Efficacy and safety of apatinib alone or apatinib plus paclitaxel/docetaxel versus paclitaxel/docetaxel in the treatment of advanced non‐small cell lung cancer: A meta‐analysis

Efficacy and safety of apatinib alone or apatinib plus paclitaxel/docetaxel versus paclitaxel/docetaxel in the treatment of advanced non‐small cell lung cancer: A meta‐analysis

Abstract Background To investigate the efficacy and safety of apatinib alone or apatinib plus paclitaxel/docetaxel versus paclitaxel/docetaxel in the treatment of advanced non‐small cell lung cancer (NSCLC) through pooling of open published data. Methods The electronic databases of Medline (1960–202...

Full description

Bibliographic Details
Main Authors: Zhe Li, Zhibao Liu, Yuanyuan Wu, Huarui Li, Zhen Sun, Chenggang Han, Xiaoling Zhang, Jinghua Zhang
Format: Article
Language:English
Published: Wiley 2021-11-01
Series:Thoracic Cancer
Subjects:
apatinib
meta‐analysis
non‐small cell lung cancer
paclitaxel/docetaxel
Online Access:https://doi.org/10.1111/1759-7714.14131

Internet

https://doi.org/10.1111/1759-7714.14131

Similar Items